AONC American Oncology Network Market Capitalization to Book Value Ratio

Corporate emblem and logo of aoncology.com (AONC)

High barriers to entry and government regulation create an oligopoly, which stabilizes the premium of market capitalization over book value; analyzing the chart on GURU.Markets, we find that -0.19 is the current metric value. The fundamentals of American Oncology Network (AONC) rely on the impeccable reputation of its clinic network and the defensive nature of oncology, where demand remains independent of GDP fluctuations and household income.

American Oncology Network, Inc. (AONC) - Market Capitalization to Book Value Ratio from 02/21/2024 to 08/04/2024
Flagship merchandise of American Oncology Network

This multiple compares the current market value of American Oncology Network (AONC) with its net assets to determine the premium for future growth. By analyzing the company's value relative to its balance sheet, an investor assesses the operational efficiency of American Oncology Network (AONC) clinics amid rising demand for oncology therapy. The metric reflects market confidence in the scalability of the outpatient care network. The stability of this ratio confirms the fundamental resilience of the business. The trend of this metric allows for a distinction between the objective value of assets and speculative expectations.

Who American Oncology Network competes with

ONC: Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio halozyme.com|RVMD (Revolution Medicines, Inc.) - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Ascentage Pharma Group International (AAPG)|Market Capitalization to Book Value Ratio CGON|Market Capitalization to Book Value Ratio UroGen Pharma Corp (URGN)|Market Value to Book Value Ratio Bicara Therapeutics Inc. BCAX|PSNL: Capitalization to Book Value Ratio|Erasca - Market Capitalization to Book Value Ratio|Delcath Systems Inc (DCTH) - Market Cap to Net Assets Ratio|YMAB: Market Capitalization to Book Value Ratio|Market-to-Book Ratio Aura Corp (AURA)|Market Value to Book Value Ratio Candel Therapeutics Inc.|ARAY: Market Value to Book Value|Market Cap to Net Assets Ratio SLS (SELLAS Life Sciences)|ACTU (Actuate Therapeutics Inc.) - Market Value to Book Value|Market Capitalization to Book Value Ratio CTOR (Citius Oncology, Inc)|HURA - Market Cap to Net Assets Ratio|TARA: Market Cap to Net Assets Ratio|FATE - Market Capitalization to Book Value Ratio|aadibio.com (WHWK) - Market Value to Book Value Ratio|TScan Therapeutics, Inc. - Market Value to Book Value|CSBR (Champions Oncology Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio XBiotech USA XBIT|Market Capitalization to Book Value Ratio CVM|Market Capitalization to Book Value Ratio ostherapies.com (OSTX)|Market Value to Book Value Ratio Radiopharm Theranostics RADX|ARTV - Market Cap to Net Assets Ratio|Adlai Nortye Limited - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Veru Corporation|Tempest Therapeutics (TPST) - Market Value to Book Value Ratio|Xilio Therapeutics - Market Value to Book Value|RENB (Renovaro Biosciences) - Market Capitalization to Book Value Ratio|Mural Bio (MURA) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio KAPA|Market Cap to Net Assets Ratio onkuretherapeutics.com OKUR|Market Capitalization to Book Value Ratio GDTC (CytoMed Therapeutics Limited)|Market Capitalization to Book Value Ratio Curis Inc. CRIS|APLM - Market Value to Book Value Ratio|THAR (Tharimmune Inc) - Capitalization to Book Value Ratio|ADVB (advanbiomed.com) - Market Cap to Net Assets Ratio|Genprex Inc - Market Value to Book Value|Market Value to Book Value Ratio Calidi Biotherapeutics Inc.|Market-to-Book Ratio sunshinebiopharma.com SBFM|Market Value to Book Value Ratio Xenetic Biosciences (XBIO)|Salarius Pharmaceuticals Inc - Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio PPBT (Purple Biotech Corp)|BGNE - Market Cap to Net Assets Ratio|CKPT - Market Value to Book Value Ratio|Market-to-Book Ratio Elevation Oncology Inc.|icadmed.com (ICAD) - Market Value to Book Value Ratio|IKNA (Ikena Oncology) - Market Value to Book Value Ratio|Market Value to Book Value Ratio Notable Labs Inc.|Market-to-Book Ratio Viracta VIRX|Market Capitalization to Book Value Ratio MOR|nayabiosciences.com (NAYA) - Market Value to Equity Ratio|Ascentage Pharma - Market Cap to Net Assets Ratio